UNSPSC 51151625: Butylscopolamine

This classification denotes an antimuscarinic agent with the molecular formula C21H30NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2Z3E1OF81V, chemically known as 3-oxa-9-azonitricyclo(3.3.1.0(2,4))nonane, 9-butyl-7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9-methyl-, (7(s)-(1alpha,2beta,4beta,5alpha,7beta))- but generally known as butylscopolamine, which bears US NIH Compound Identifier 160883. Butylscopolamine most often comes in base and bromide forms.

UNSPSC 51151625 Butylscopolamine is a Commodity code with a significant mismatch between its nominal scope and the recent state and local solicitations tagged under it. The recent opportunities show no procurement activity for butylscopolamine itself; instead, they document purchases of naloxone (opioid reversal) and pharmacy benefit management services. State and local governments do not appear to be actively soliciting butylscopolamine through the tracked opportunities that carry this code tag.

The two most recent state and local opportunities under this code are Seminole County, Florida's IFB for naloxone and drug deactivation systems (posted June 30, 2026, with a July 26, 2023 deadline for 1,900 units of naloxone and 800 safe drug deactivation systems annually), and the Texas Health and Human Services Commission's Request for Information on direct-to-manufacturer prescription programs (posted April 3, 2026). Neither opportunity is pharmaceutically aligned with butylscopolamine procurement. The code shows little relevant recent activity and appears to be misaligned with the actual work being bought in these instances.